Home
>
National Drug Code (NDC)
>
Lantus
Lantus - 55045-3685-1 - (insulin glargine)
Drug Information of Lantus
| Product NDC: | 55045-3685 |
| Proprietary Name: | Lantus |
| Non Proprietary Name: | insulin glargine |
| Active Ingredient(s): | 100 [iU]/mL & nbsp; insulin glargine |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Lantus
| Product NDC: | 55045-3685 |
| Labeler Name: | Dispensing Solutions, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021081 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090923 |
Package Information of Lantus
| Package NDC: | 55045-3685-1 |
| Package Description: | 10 mL in 1 VIAL, GLASS (55045-3685-1) |
NDC Information of Lantus
| NDC Code | 55045-3685-1 |
| Proprietary Name | Lantus |
| Package Description | 10 mL in 1 VIAL, GLASS (55045-3685-1) |
| Product NDC | 55045-3685 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | insulin glargine |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20090923 |
| Marketing Category Name | NDA |
| Labeler Name | Dispensing Solutions, Inc. |
| Substance Name | INSULIN GLARGINE |
| Strength Number | 100 |
| Strength Unit | [iU]/mL |
| Pharmaceutical Classes | Insulin [Chemical/Ingredient],Insulin Analog [EPC] |
